v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 22,108 $ 13,124 $ 42,402 $ 23,098
General and administrative 7,021 5,558 13,865 11,260
Total operating expenses 29,129 18,682 56,267 34,358
Loss from operations (29,129) (18,682) (56,267) (34,358)
Other income (expense):        
Interest income 2,112 1,683 3,673 3,510
Interest expense (491) (646) (1,036) (1,244)
Loss on debt extinguishment 0 0 0 (681)
Other, net (130) (61) (245) (102)
Total other income, net 1,491 976 2,392 1,483
Net loss (27,638) (17,706) (53,875) (32,875)
Other comprehensive income (loss):        
Change in fair value attributable to instrument specific credit risk 0 22 7 156
Foreign currency translation 4 (5) (12) (24)
Total other comprehensive income (loss) 4 17 (5) 132
Comprehensive loss $ (27,634) $ (17,689) $ (53,880) $ (32,743)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.65) $ (0.65) $ (1.34) $ (1.21)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.65) $ (0.65) $ (1.34) $ (1.21)
Weighted-average number of common shares outstanding, basic (in shares) 42,813,000 27,072,000 40,179,000 27,061,000
Weighted-average number of common shares outstanding, diluted (in shares) 42,813,000 27,072,000 40,179,000 27,061,000